Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
e6D6dZG5y4yuFuP1
Français